Pharmaceutical Business review

AlphaRx to raise $1.6 million in private placement

Each unit consists of one common share plus one-half common share purchase warrant. Each whole common share purchase warrant will enable the holder to purchase one common share at a price of $0.125 for a period of 24 months from closing. Closing of the private placement is subject to the company’s common shares being listed and posted for trading on the TSX Venture Exchange.

Exit mobile version